Products
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | 3.0 | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 2.1 | - |
NAV | ₹31.01 | - |
Fund Started | 04 Dec 2015 | - |
Fund Size | ₹1308.56 Cr | - |
Exit Load | Exit load of 0.25% if redeemed within 30 days. | - |
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹100
-
Expense Ratio
2.1
-
NAV
₹31.01
-
Fund Started
04 Dec 2015
-
Fund Size
₹1308.56 Cr
-
Exit Load
Exit load of 0.25% if redeemed within 30 days.
-
Returns
1 Year | -1.47% | - |
3 Year | 23.49% | - |
5 Year | 19.42% | - |
1 Year
-1.47%
-
3 Year
23.49%
-
5 Year
19.42%
-
Holding Analysis
Equity | 97.44% | - |
Cash | 2.56% | - |
Equity
97.44%
-
Cash
2.56%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 9.94% |
Cipla Ltd. | 6.92% |
Apollo Hospitals Enterprise Ltd. | 5.15% |
Healthcare Global Enterprises Ltd. | 4.85% |
Lupin Ltd. | 4.79% |
Torrent Pharmaceuticals Ltd. | 4.58% |
Aster DM Healthcare Ltd. | 4.40% |
Alkem Laboratories Ltd. | 4.31% |
Max Healthcare Institute Ltd. | 4.05% |
Divi's Laboratories Ltd. | 3.90% |
-
Fund Manager
Name | Meeta Shetty | - |
Start Date | 09 Nov 2018 | - |
Name
Meeta Shetty
-
Start Date
09 Nov 2018
-
About Fund
Description | The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. | - |
Launch Date | 04 Dec 2015 | - |
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
-
Launch Date
04 Dec 2015
-
